340 related articles for article (PubMed ID: 35340126)
1. m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency.
Li G; Luo R; Zhang W; He S; Wang B; Liang H; Song Y; Ke W; Shi Y; Feng X; Zhao K; Wu X; Zhang Y; Wang K; Yang C
Clin Transl Med; 2022 Mar; 12(3):e765. PubMed ID: 35340126
[TBL] [Abstract][Full Text] [Related]
2. METTL3 promotes nucleus pulposus cell senescence in intervertebral disc degeneration by regulating TLR2 m6A methylation and gut microbiota.
Ni S; Huang X; Li X; Shi C; Fan M; Zhao L; Rong Z; Zhang H
J Gerontol A Biol Sci Med Sci; 2024 Jun; ():. PubMed ID: 38853707
[TBL] [Abstract][Full Text] [Related]
3. M6A methylation-regulated autophagy may be a new therapeutic target for intervertebral disc degeneration.
Tao Y; Yu X; Li X; Xu Y; Wang H; Zhang L; Lin R; Wang Y; Fan P
Cell Biol Int; 2024 Apr; 48(4):389-403. PubMed ID: 38317355
[TBL] [Abstract][Full Text] [Related]
4. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
5. Abnormal stress promotes intervertebral disc degeneration through WTAP/YTHDF2-dependent TIMP3 m6A modification.
Gao D; Zhao Q; Liu C; Zhang Y; Xiao L
J Cell Physiol; 2024 May; 239(5):e31219. PubMed ID: 38345407
[TBL] [Abstract][Full Text] [Related]
6. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
7. SIAH1 promotes senescence and apoptosis of nucleus pulposus cells to exacerbate disc degeneration through ubiquitinating XIAP.
Fang S; Zeng F; Chen R; Li M
Tissue Cell; 2022 Jun; 76():101820. PubMed ID: 35580525
[TBL] [Abstract][Full Text] [Related]
8. WTAP-mediated m
Li G; Ma L; He S; Luo R; Wang B; Zhang W; Song Y; Liao Z; Ke W; Xiang Q; Feng X; Wu X; Zhang Y; Wang K; Yang C
Nat Commun; 2022 Mar; 13(1):1469. PubMed ID: 35304463
[TBL] [Abstract][Full Text] [Related]
9. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
10. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
11. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction.
Gao X; Liang X; Liu B; Hong Y; He H; Shen Y; Chen J; Huang X; Hu B; Li W; Li X; Zhang Y
FASEB J; 2023 Dec; 37(12):e23294. PubMed ID: 37966425
[TBL] [Abstract][Full Text] [Related]
13. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
[TBL] [Abstract][Full Text] [Related]
14. ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression.
Ye G; Li J; Yu W; Xie Z; Zheng G; Liu W; Wang S; Cao Q; Lin J; Su Z; Li D; Che Y; Fan S; Wang P; Wu Y; Shen H
Exp Mol Med; 2023 Aug; 55(8):1743-1756. PubMed ID: 37524872
[TBL] [Abstract][Full Text] [Related]
15. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
16. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.
Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J
Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466
[TBL] [Abstract][Full Text] [Related]
17. Disassembly of the TRIM56-ATR complex promotes cytoDNA/cGAS/STING axis-dependent intervertebral disc inflammatory degeneration.
Zhang W; Li G; Zhou X; Liang H; Tong B; Wu D; Yang K; Song Y; Wang B; Liao Z; Ma L; Ke W; Zhang X; Lei J; Lei C; Feng X; Wang K; Zhao K; Yang C
J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38488012
[TBL] [Abstract][Full Text] [Related]
18. Upregulated lnc‑HRK‑2:1 prompts nucleus pulposus cell senescence in intervertebral disc degeneration.
Liang D; Hong D; Tang F; Wang Y; Li J; Li L; Chen H
Mol Med Rep; 2020 Dec; 22(6):5251-5261. PubMed ID: 33174041
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency".
Clin Transl Med; 2023 Aug; 13(8):e1353. PubMed ID: 37525589
[No Abstract] [Full Text] [Related]
20. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
